{"id":6108,"date":"2025-02-14T12:42:40","date_gmt":"2025-02-14T11:42:40","guid":{"rendered":"https:\/\/pharmalundensis.se\/?p=6108"},"modified":"2025-02-14T12:42:40","modified_gmt":"2025-02-14T11:42:40","slug":"publication-of-rights-issue-material","status":"publish","type":"post","link":"https:\/\/pharmalundensis.se\/en\/publication-of-rights-issue-material\/","title":{"rendered":"Publication of rights issue material"},"content":{"rendered":"<p>PharmaLundensis rights issue is available 13 -27 february.<\/p>\n<p><span style=\"color: #000080\"><a style=\"color: #000080\" href=\"https:\/\/pharmalundensis.se\/wp-content\/uploads\/sites\/43\/2025\/02\/VD-brev_2025_EN_web.pdf\">Message from the CEO<\/a><\/span><br \/>\n<span style=\"color: #000080\"><a style=\"color: #000080\" href=\"https:\/\/pharmalundensis.se\/wp-content\/uploads\/sites\/43\/2025\/02\/Memorandum-Feb-2025.pdf\">Memorandum Feb 2025<\/a> (in Swedish)<\/span><br \/>\n<span style=\"color: #000080\"><a style=\"color: #000080\" href=\"https:\/\/pharmalundensis.se\/wp-content\/uploads\/sites\/43\/2025\/02\/Teckning-utan-foretrade-Pharmalundensis-Interaktiv.pdf\">Teckning utan f\u00f6retr\u00e4de Interaktiv (in Swedish)<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PharmaLundensis rights issue is available 13 -27 february. Message from the CEO Memorandum Feb 2025 (in Swedish) Teckning utan f\u00f6retr\u00e4de [&hellip;]<\/p>\n","protected":false},"author":70,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[24],"tags":[],"class_list":["post-6108","post","type-post","status-publish","format-standard","hentry","category-uncategorized-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Publication of rights issue material - Pharmalundensis<\/title>\n<meta name=\"description\" content=\"PharmaLundensis rights issue is available 13 -27 february. Message from the CEO Memorandum Feb 2025 (in Swedish) Teckning utan f\u00f6retr\u00e4de Interaktiv (in\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharmalundensis.se\/en\/publication-of-rights-issue-material\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Publication of rights issue material - Pharmalundensis\" \/>\n<meta property=\"og:description\" content=\"PharmaLundensis rights issue is available 13 -27 february. Message from the CEO Memorandum Feb 2025 (in Swedish) Teckning utan f\u00f6retr\u00e4de Interaktiv (in\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharmalundensis.se\/en\/publication-of-rights-issue-material\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharmalundensis\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-14T11:42:40+00:00\" \/>\n<meta name=\"author\" content=\"staffan\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"staffan\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/en\\\/publication-of-rights-issue-material\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/en\\\/publication-of-rights-issue-material\\\/\"},\"author\":{\"name\":\"staffan\",\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/#\\\/schema\\\/person\\\/c9d3434afcbe17a34ed68b88c5e849e2\"},\"headline\":\"Publication of rights issue material\",\"datePublished\":\"2025-02-14T11:42:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/en\\\/publication-of-rights-issue-material\\\/\"},\"wordCount\":28,\"publisher\":{\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/#organization\"},\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/en\\\/publication-of-rights-issue-material\\\/\",\"url\":\"https:\\\/\\\/pharmalundensis.se\\\/en\\\/publication-of-rights-issue-material\\\/\",\"name\":\"Publication of rights issue material - Pharmalundensis\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/#website\"},\"datePublished\":\"2025-02-14T11:42:40+00:00\",\"description\":\"PharmaLundensis rights issue is available 13 -27 february. Message from the CEO Memorandum Feb 2025 (in Swedish) Teckning utan f\u00f6retr\u00e4de Interaktiv (in\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/en\\\/publication-of-rights-issue-material\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharmalundensis.se\\\/en\\\/publication-of-rights-issue-material\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/en\\\/publication-of-rights-issue-material\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/pharmalundensis.se\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publication of rights issue material\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/#website\",\"url\":\"https:\\\/\\\/pharmalundensis.se\\\/\",\"name\":\"Pharmalundensis\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharmalundensis.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/#organization\",\"name\":\"Pharmalundensis\",\"url\":\"https:\\\/\\\/pharmalundensis.se\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharmalundensis\"},\"image\":{\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/#\\\/schema\\\/person\\\/c9d3434afcbe17a34ed68b88c5e849e2\",\"name\":\"staffan\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6410d9a147ae7a88f9017675b041584ae6f4c52608381c8ecbf7671fbf4fde26?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6410d9a147ae7a88f9017675b041584ae6f4c52608381c8ecbf7671fbf4fde26?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6410d9a147ae7a88f9017675b041584ae6f4c52608381c8ecbf7671fbf4fde26?s=96&d=mm&r=g\",\"caption\":\"staffan\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Publication of rights issue material - Pharmalundensis","description":"PharmaLundensis rights issue is available 13 -27 february. Message from the CEO Memorandum Feb 2025 (in Swedish) Teckning utan f\u00f6retr\u00e4de Interaktiv (in","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharmalundensis.se\/en\/publication-of-rights-issue-material\/","og_locale":"en_US","og_type":"article","og_title":"Publication of rights issue material - Pharmalundensis","og_description":"PharmaLundensis rights issue is available 13 -27 february. Message from the CEO Memorandum Feb 2025 (in Swedish) Teckning utan f\u00f6retr\u00e4de Interaktiv (in","og_url":"https:\/\/pharmalundensis.se\/en\/publication-of-rights-issue-material\/","og_site_name":"Pharmalundensis","article_published_time":"2025-02-14T11:42:40+00:00","author":"staffan","twitter_card":"summary_large_image","twitter_misc":{"Written by":"staffan","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharmalundensis.se\/en\/publication-of-rights-issue-material\/#article","isPartOf":{"@id":"https:\/\/pharmalundensis.se\/en\/publication-of-rights-issue-material\/"},"author":{"name":"staffan","@id":"https:\/\/pharmalundensis.se\/#\/schema\/person\/c9d3434afcbe17a34ed68b88c5e849e2"},"headline":"Publication of rights issue material","datePublished":"2025-02-14T11:42:40+00:00","mainEntityOfPage":{"@id":"https:\/\/pharmalundensis.se\/en\/publication-of-rights-issue-material\/"},"wordCount":28,"publisher":{"@id":"https:\/\/pharmalundensis.se\/#organization"},"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharmalundensis.se\/en\/publication-of-rights-issue-material\/","url":"https:\/\/pharmalundensis.se\/en\/publication-of-rights-issue-material\/","name":"Publication of rights issue material - Pharmalundensis","isPartOf":{"@id":"https:\/\/pharmalundensis.se\/#website"},"datePublished":"2025-02-14T11:42:40+00:00","description":"PharmaLundensis rights issue is available 13 -27 february. Message from the CEO Memorandum Feb 2025 (in Swedish) Teckning utan f\u00f6retr\u00e4de Interaktiv (in","breadcrumb":{"@id":"https:\/\/pharmalundensis.se\/en\/publication-of-rights-issue-material\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharmalundensis.se\/en\/publication-of-rights-issue-material\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharmalundensis.se\/en\/publication-of-rights-issue-material\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/pharmalundensis.se\/en\/"},{"@type":"ListItem","position":2,"name":"Publication of rights issue material"}]},{"@type":"WebSite","@id":"https:\/\/pharmalundensis.se\/#website","url":"https:\/\/pharmalundensis.se\/","name":"Pharmalundensis","description":"","publisher":{"@id":"https:\/\/pharmalundensis.se\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharmalundensis.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharmalundensis.se\/#organization","name":"Pharmalundensis","url":"https:\/\/pharmalundensis.se\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharmalundensis.se\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharmalundensis"},"image":{"@id":"https:\/\/pharmalundensis.se\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharmalundensis.se\/#\/schema\/person\/c9d3434afcbe17a34ed68b88c5e849e2","name":"staffan","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/6410d9a147ae7a88f9017675b041584ae6f4c52608381c8ecbf7671fbf4fde26?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/6410d9a147ae7a88f9017675b041584ae6f4c52608381c8ecbf7671fbf4fde26?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6410d9a147ae7a88f9017675b041584ae6f4c52608381c8ecbf7671fbf4fde26?s=96&d=mm&r=g","caption":"staffan"}}]}},"rttpg_featured_image_url":null,"rttpg_author":{"display_name":"staffan","author_link":"https:\/\/pharmalundensis.se\/en\/author\/staffan\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/pharmalundensis.se\/en\/category\/uncategorized-en\/\" rel=\"category tag\">Uncategorized<\/a>","rttpg_excerpt":"PharmaLundensis rights issue is available 13 -27 february. Message from the CEO Memorandum Feb 2025 (in Swedish) Teckning utan f\u00f6retr\u00e4de [&hellip;]","_links":{"self":[{"href":"https:\/\/pharmalundensis.se\/en\/wp-json\/wp\/v2\/posts\/6108","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmalundensis.se\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmalundensis.se\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmalundensis.se\/en\/wp-json\/wp\/v2\/users\/70"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmalundensis.se\/en\/wp-json\/wp\/v2\/comments?post=6108"}],"version-history":[{"count":0,"href":"https:\/\/pharmalundensis.se\/en\/wp-json\/wp\/v2\/posts\/6108\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharmalundensis.se\/en\/wp-json\/wp\/v2\/media?parent=6108"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmalundensis.se\/en\/wp-json\/wp\/v2\/categories?post=6108"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmalundensis.se\/en\/wp-json\/wp\/v2\/tags?post=6108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}